A new drug developed by QIMR Berghofer could transform the treatment of COVID-19 by potentially protecting against infection by any SARS-CoV-2 variant and reversing the persistent inflammation that is a major driver of debilitating long COVID.

  • BedSharkPal@kbin.socialOP
    link
    fedilink
    English
    arrow-up
    6
    ·
    1 year ago

    The fluff usually makes it a bit more approachable to the layperson though. Maybe require a link to the actual abstract as well?

    • swope@kbin.social
      link
      fedilink
      English
      arrow-up
      3
      ·
      edit-2
      1 year ago

      I don’t want to require anything. Just makes things harder for posters and mods who have another rule to enforce.

      If the link to the journal or whatever they original cite is is useful, folks will upvote the comment.